XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Convertible Preferred Stock, Redeemable Noncontrolling Interest and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Class A and Class B Common Stock
Common Class A And B
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jan. 31, 2023 $ 1,455          
Noncontrolling Interest [Roll Forward]            
Net loss attributable to redeemable non-controlling interest (727)          
Ending balance at Jul. 31, 2023 728          
Beginning balance (in shares) at Jan. 31, 2023     95,975,000      
Beginning balance at Jan. 31, 2023 445,303   $ 10 $ 806,044 $ (353,927) $ (6,824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for options exercised (in shares)     1,249,000      
Issuance of common stock for options exercised 4,111     4,111    
Issuance of common stock under employee stock purchase plan (in shares)     128,000      
APIC, Share-based Payment Arrangement, Option, Early Exercised, Increase for Cost Recognition 3,222     3,222    
Repurchase of shares related to early exercised options (in shares)     656,000      
Stock-based compensation 49,972     49,972    
Other comprehensive income 947         947
Charitable donation of stock (in shares)     32,000      
Charitable donation of stock 964     964    
Issuance of common stock from acquisition (in shares)     190,000      
Issuance of common stock from acquisition 6,000     6,000    
Net Income (Loss) (70,148)       (70,148)  
Ending balance at Jul. 31, 2023 440,371 $ 10 $ 10 870,313 (424,075) (5,877)
Ending balance (in shares) at Jul. 31, 2023   98,230,000 98,230,000      
Beginning balance at Apr. 30, 2023 1,083          
Noncontrolling Interest [Roll Forward]            
Net loss attributable to redeemable non-controlling interest (355)          
Ending balance at Jul. 31, 2023 728          
Beginning balance (in shares) at Apr. 30, 2023     96,864,000      
Beginning balance at Apr. 30, 2023 435,149   $ 10 832,831 (392,381) (5,311)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for options exercised (in shares)     573,000      
Issuance of common stock for options exercised 1,900     1,900    
Issuance of common stock under employee stock purchase plan (in shares)     128,000      
Issuance of common stock under employee stock purchase plan 3,222     3,222    
Vesting of restricted stock units (in shares)     443,000      
Stock-based compensation 25,396     25,396    
Other comprehensive income (566)          
Charitable donation of stock (in shares)     32,000      
Charitable donation of stock $ 964     964    
Issuance of common stock from acquisition (in shares) 190,000          
Issuance of common stock from acquisition $ 6,000          
Net Income (Loss) (31,694)       (31,694)  
Ending balance at Jul. 31, 2023 440,371 $ 10 $ 10 870,313 (424,075) (5,877)
Ending balance (in shares) at Jul. 31, 2023   98,230,000 98,230,000      
Beginning balance at Jan. 31, 2024 192          
Noncontrolling Interest [Roll Forward]            
Net loss attributable to redeemable non-controlling interest (216)          
Ending balance at Jul. 31, 2024 (24)          
Beginning balance (in shares) at Jan. 31, 2024     100,210,000      
Beginning balance at Jan. 31, 2024 444,233   $ 10 928,494 (483,093) (1,178)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for options exercised (in shares)     401,000      
Issuance of common stock for options exercised 2,205     2,205    
Issuance of common stock under employee stock purchase plan (in shares)     149,000      
Issuance of common stock under employee stock purchase plan 4,752     4,752    
Vesting of restricted stock units (in shares)     1,165,000      
Stock-based compensation 58,871     58,871    
Other comprehensive income 925         925
Charitable donation of stock (in shares)     32,000      
Charitable donation of stock 1,347     1,347    
Net Income (Loss) (58,640)       (58,640)  
Ending balance at Jul. 31, 2024 453,693   $ 10 995,669 (541,733) (253)
Ending balance (in shares) at Jul. 31, 2024     101,957,000      
Beginning balance at Apr. 30, 2024 126          
Noncontrolling Interest [Roll Forward]            
Net loss attributable to redeemable non-controlling interest (150)          
Ending balance at Jul. 31, 2024 (24)          
Beginning balance (in shares) at Apr. 30, 2024     101,020,000      
Beginning balance at Apr. 30, 2024 436,107   $ 10 958,224 (518,734) (3,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for options exercised (in shares)     168,000      
Issuance of common stock for options exercised 1,170     1,170    
Issuance of common stock under employee stock purchase plan (in shares)     149,000      
Issuance of common stock under employee stock purchase plan 4,752     4,752    
Vesting of restricted stock units (in shares)     588,000      
Stock-based compensation 30,176     30,176    
Other comprehensive income 3,140         3,140
Charitable donation of stock (in shares)     32,000      
Charitable donation of stock 1,347     1,347    
Net Income (Loss) (22,999)       (22,999)  
Ending balance at Jul. 31, 2024 $ 453,693   $ 10 $ 995,669 $ (541,733) $ (253)
Ending balance (in shares) at Jul. 31, 2024     101,957,000